🇺🇸 FDA
Patent

US 8895553

Oligomer-containing substituted aromatic triazine compounds

granted A61KA61K31/53A61K47/60

Quick answer

US patent 8895553 (Oligomer-containing substituted aromatic triazine compounds) held by Nektar Therapeutics expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/53, A61K47/60, A61P, A61P25/04